Your browser doesn't support javascript.
loading
A Pharmacoeconomic Analysis to Determine the Relative Cost-effectiveness of Timolol 0.5%, Brinzolamide 1% and Brimonidine 0.2% Eye Drops in Treatment of Primary Open Angle Glaucoma/Ocular Hypertension
Article | IMSEAR | ID: sea-183634
Full text: 1 Index: IMSEAR Type of study: Clinical_trials / Health_economic_evaluation / Observational_studies Year: 2019 Type: Article
Full text: 1 Index: IMSEAR Type of study: Clinical_trials / Health_economic_evaluation / Observational_studies Year: 2019 Type: Article